Randall E. Kaye
2023
In 2023, Randall E. Kaye earned a total compensation of $1.2M as Executive Vice President and Chief Medical Officer at Longboard Pharmaceuticals, a 16% decrease compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $228,690 |
---|---|
Option Awards | $443,113 |
Salary | $472,500 |
Other | $16,764 |
Total | $1,161,067 |
Kaye received $472.5K in salary, accounting for 41% of the total pay in 2023.
Kaye also received $228.7K in non-equity incentive plan, $443.1K in option awards and $16.8K in other compensation.
Rankings
In 2023, Randall E. Kaye's compensation ranked 1,038th out of 2,918 executives tracked by ExecPay. In other words, Kaye earned more than 64.4% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 1,038 | 64th |
Manufacturing | 621 | 61st |
Chemicals And Allied Products | 428 | 53rd |
Drugs | 417 | 52nd |
Pharmaceutical Preparations | 285 | 54th |
Kaye's colleagues
We found two more compensation records of executives who worked with Randall E. Kaye at Longboard Pharmaceuticals in 2023.